Edition:
United Kingdom

ContraFect Corp (CFRX.OQ)

CFRX.OQ on NASDAQ Stock Exchange Capital Market

1.17USD
5:32pm GMT
Change (% chg)

$-0.00 (-0.42%)
Prev Close
$1.18
Open
$1.17
Day's High
$1.18
Day's Low
$1.17
Volume
7,607
Avg. Vol
24,527
52-wk High
$2.45
52-wk Low
$0.80

Chart for

About

ContraFect Corporation is a clinical-stage biotechnology company. The Company is focused on discovering and developing therapeutic protein and antibody products for the treatment of infectious diseases, including those caused by drug-resistant pathogens, particularly those treated in hospital settings. Its pipeline of lysin... (more)

Overall

Beta: --
Market Cap(Mil.): $95.02
Shares Outstanding(Mil.): 73.66
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 85.70 16.62
EPS (TTM): -- -- --
ROI: -- 3.19 10.61
ROE: -- 4.52 14.21

BRIEF-ContraFect announces Q3 loss per share $0.02

* ContraFect Corp - ‍As of Sept 30, 2017, had cash, cash equivalents and marketable securities of $52.6 million compared to $35.2 million as of December 31, 2016​ Source text for Eikon: Further company coverage:

09 Nov 2017

Earnings vs. Estimates